I got to Halstead Diagnostics at 1:35. I couldn’t sit still at home.
Tasha came out from behind the desk the moment I walked in. She didn’t make me wait. She walked me down a short hallway to a corner office with diplomas on the wall and a window that looked out at the parking lot.
Dr. Reeves was sitting behind his desk, reading a report. He was in his late fifties, I’d guess, with gray hair cut very short and wire glasses. He stood up when I came in and shook my hand.
“Mrs. Bennett. Thank you for coming. Please, sit down.”
I sat in the chair across from him. I put my purse in my lap and held onto the strap with both hands.
He sat back down and looked at the report again. Then he looked up at me.
Then he looked past me, at the office door. Tasha had left it open a few inches when she went back to the front.
His face went very serious. More serious than any doctor had ever looked at me, even the one in the emergency room who told me about Tom.
He stood up. He walked around his desk. He closed the door quietly, and I heard the latch click. Then he went back to his chair and sat down slowly.
“Mrs. Bennett,” he said carefully, “does your husband know you came here?”
My mouth went dry.
“No,” I whispered.
“Does anyone know? Your family? A friend?”
“No one. Not yet.”
He nodded slowly. He took off his glasses and rubbed his eyes.
“Doctor, please. Tell me. Is there something in that drink I should be worried about?”
He didn’t answer right away. He put his glasses back on. He looked down at the report. I watched him choose his words the way I used to choose mine when I had to tell a parent their child was failing.
“The sample you brought us contained a prescription medication,” he said. “A sedative. One that affects memory and attention. In the amounts we found, taken every night, it would absolutely explain fatigue, confusion, and memory lapses. The kind of symptoms that can look, to a family doctor, like the early stages of dementia.”
I couldn’t breathe. I held onto my purse strap so hard my knuckles went white.
“There was something else in the sample as well,” he went on. “A second compound. One I didn’t recognize. We had to run it through a reference database to identify it.”
“What is it?”
He hesitated.
“It’s not on the market, Mrs. Bennett. It’s not approved. It’s an investigational drug.”
“I don’t understand. What does that mean?”
“It means it’s still being tested. In clinical trials. On human subjects.”
The room went very quiet. I could hear the air conditioning hum. I could hear a car door close somewhere outside in the parking lot.
“When a compound like that shows up,” Dr. Reeves said, “we’re required to check whether the patient is enrolled in an active study. There’s a registry. I ran your name and your date of birth this morning.”
He didn’t say anything else. He just reached over and turned his computer screen toward me.
Specialty: Legal & Financial Drama
Michael Carter covers stories where money, power, and personal history collide. His writing often explores courtroom battles, business conflicts, and the subtle strategies people use when pushed into a corner. He focuses on grounded, realistic storytelling with attention to detail and believable motivations.